Effect of onion and beet on plasma and liver lipids, platelet aggregation, and erythrocyte Na efflux in simvastatin treated hypercholesterolmic rats by Kim, Jung Lye et al.
Nutrition Research and Practice (2008), 2(4), 211-217
ⓒ2008 The Korean Nutrition Society and the Korean Society of Community Nutrition
Effect of onion and beet on plasma and liver lipids, platelet aggregation, and 
erythrocyte Na efflux in simvastatin treated hypercholesterolmic rats*
Jung Lye Kim
1, In Sook Chae
1, Young Hee Kang
2  and Jung Sook Kang
1§
1Department of Foods & Nutrition, Cheju National University, 1 Ara-dong, Jeju-si, Jeju 690-756, Korea 
2Division of life Sciences and Institute of Environment and Life Science, Hallym University, 1 Okchun-dong, Chuncheon-si, Gangwon
200-702, Korea 
Received October 7, 2008, Revised November 20, 2008, Accepted December 6, 2008
Abstract
This study was purposed to investigate the effect of onion or beet on plasma and liver lipids, erythrocyte Na efflux channels and platelet aggregation
in simvastatin (SIM) treated hypercholesterolemic rats. Forty Sprague Dawley rats were divided into four groups and fed 0.5% cholesterol  based 
diets containing 2 mg/kg BW simvastatin or simvastatin with 5% onion or beet powder. Plasma total cholesterol was significantly increased in
SIM group compared with the control (p<0.01), and the elevated plasma total cholesterol of SIM group was significantly decreased in SIM-onion
and SIM-beet groups (p<0.05). HDL-cholesterol in SIM-beet group was significantly increased compared with other groups (p<0.05). Platelet aggregation
in both the maximum and initial slope was significantly decreased in SIM group compared with SIM-onion group (p<0.05). Na-K ATPase was
significantly decreased in SIM group compared with the control, SIM-onion and SIM-beet groups (p<0.05). Na passive leak was significantly increased
in all groups treated with SIM compared with the control (p<0.05). The total Na efflux was decreased in SIM group and increased in SIM-onion 
group and the difference between these two groups was significant (p<0.05). There was no difference in intracellular Na among groups. In present
study, simvastatin, a HMG CoA reductase inhibitor at dose of 2mg/kg BW/day rather increased plasma total cholesterol in rats, inferring that the
action mechanism of simvastatin on cholesterol metabolism differ between rat and human. Onion and beet play favorable roles in cardiovascular
system by restoring the reduced Na efflux through Na-K ATPase and Na-K cotransport in SIM treated rats. 
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Introduction4)
According to American Heart Association Report, cardiovascular 
disease (CVD) is a major cause of death in US and the death 
rate of 35.2% is accounted from CVD in 2005 (Rosamond et 
al., 2008). Elevated plasma cholesterol is one of the major risk 
factors in developing cardiovascular diseases, and an intervention 
study showed that reduction of total cholesterol by 11.5% 
reduced CVD events by 33% (Nakamura et al., 2007). Statin, 
a HMG CoA reductase inhibitor is recognized as one of the most 
popular drug lowering cholesterol in human. Among US adults 
aged≥40years with hypertension, 14.5% are taking statin 
medication in NHANES (1999-2002) study (King et al., 2007). 
Statin is known to deplete coenzyme Q10 (CoQ10) that shares 
cholesterol biosynthetic pathway, resulting in decreased antioxidant 
capacity. The reduced form of CoQ10 (CoQH2), ubiquinol in 
plasma membrane functions as radical scavenger, protecting cell 
membrane from oxidative damage (Mabuchi et al., 2005). Nitric 
oxide (NO) that plays a dual role as deleterious radical species 
and beneficial species can be induced by statin (Fontaine et al., 
2002). Statin dependant endothelial nitric oxide synthetase (NOS) 
affected Na-K ATPase and Na-K cotransport in rat renal tubule 
(Varela et al., 2004). Statin may influence membrane ion channel 
by changing membrane lipids, thereby affecting membrane 
fluidity. Membrane fluidity of erythrocyte was increased with 
decreasing plasma cholesterol by statin therapy (Broncel et al., 
2007). NO inhibited platelet aggregation through cyclic GTP 
pathway in simvastatin treated rabbit (Chou et al., 2008). A NO 
donor, nitro-L-arginine methyl ester (L-NAME) or antioxidant 
quercetin and catechin exerted antiplatelet effects by inhibiting 
NADPH oxidase and increasing NO (Pignatelli  et al., 2006). 
Betalain pigments which are present in red beet (Beta vulgaris 
L.) root and prickly pear cactus (Opuntia ficus indica) fruit are 
recently recognized as bioavailable natural radical scavengers. 
Tesoriere et al. (2005) reported that betalain metabolite, betanin 
and indicaxanthin were observed in LDL fraction at 3 hours after 
ingestion of prickly pear cactus fruit and the resistance of LDL 
particles to ex vivo induced oxidation was increased. Cationized 
antioxidants in red beet inhibit lipid peroxidation in membranes 
or linoleate emulsion and prevent H(2)O(2)-activated LDL oxidation 
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Table 1. Composition of experimental diets (%)
Ingredient
Control Simvastatin Simvastatin
+Onion
Simvastatin
+Beet
Cholesterol based diet
Casein
a) 20 20 20 20
L-methionine
a) 0.3 0.3 0.3 0.3
Lard 9.0 9.0 9.0 9.0
Soybean Oil 1.0 1.0 1.0 1.0
Choline chloride
b) 0.2 0.2 0.2 0.2
Vitamin mix
a) 1.0 1.0 1.0 1.0
Mineral mix
c) 3.5 3.5 3.5 3.5
S u c r o s e 2 02 02 02 0
Corn starch 39.3 39.3 39.3 39.3
Cellulose
d) 55- -
Cholesterol
d) 0.5 0.5 0.5 0.5
Cholic acid
d) 0.2 0.2 0.2 0.2
Simvastatin
e) - 2 mg/kg BW 2 mg/kg BW 2 mg/kg BW
Onion powder
g) --5-
Beet powder
g) ---5
Total (%) 100.0 00.0 100.0 100.0
a) Teklad,  Harlan  Madison  WI,  USA 
b) Junsei  Chemical
  Co.,  Ltd.
c) Mineral mixture (g/100 g) : CaHPO4  50.0, NaCl 7.4, K3C6H5O7  H2O 22.0, K2SO4 
5.2, MgO 2.4, Manganous carbonate (43-48% Mn) 0.35, Ferric citrate (16.7% Fe) 
0.6,  Zinc  carbonate  (70%  Zn)  0.16,  Cupric  carbonate  (53-55%  Cu) 0 .0 3 , K IO 3 
0.001,  Na2SeO3․5H2O  0.001,  CrK(SO4)2․12H2O  0.055,  Sucrose  11.804
d) Sigma  Chemical  Co.,  USA
e) Simvastatin, Choongwae Pharm. Co., Korea. 2 mg/kg BW, calculated from the 
daily  food  consumption
g) Onion and beet after cut and freeze dried were powdered (Jeju Agri Devel Tech 
Exten  Center).
at relatively low concentration (Kanner et al., 2001). Quercetin 
which is abundant in most fruits and vegetables is the major 
type of flavonoid in onion (Allium cepa). Yamamoto et al. (2005) 
have shown that the green-leafy Welsh onion reduced superoxide 
generation by suppressing the angiotensin II production and then 
the NADH/NADPH oxidase activity, increasing the NO availability 
in the aorta and consequently lowering blood pressure in the rats 
fed with a high fat diet. Continuous ingestion of onion soup 
inhibits collagen induced platelet aggregation in human by inhibiting 
collagen stimulated tyrosine phosphorylation (Hubbard et al., 2006) 
We hypothesized that statin therapy may affect some cardiovascular 
related parameters such as erythrocyte efflux channels, platelet 
aggregation besides cholesterol lowering effect by way of its own 
function on erythrocyte Na channel and platelet aggregation or 
by depletion of CoQ10 and induction of NO, and antioxidant 
rich foods such as onion and beet may reverse or interact statin 
action on these parameters.
Materials and Methods
Animals and diets 
Forty of twelve weeks old Sprague Dawley rats (Orient Bio 
Co., Ltd, Korea) were divided into four groups and fed the 
following diets: Control; 0.5% cholesterol based diet: Simvastatin 
(Choongwae Pharm. Co., Korea); the control diet plus 2 mg/kg 
BW simvastatin: Sim-onion; the simvastatin diet plus 5% onion 
powder: Sim-beet; the simvastatin diet plus 5% beet powder. Rats 
had free access to water and were housed individual cages in 
a room maintained at 20-25℃ with a 12 hour dark-light cycle. 
After 4 weeks ad libitum feeding, blood samples were obtained 
by cardiac puncture into heparinized vacuum tubes, and platelet 
aggregation and erythrocyte Na efflux were performed with fresh 
blood. Liver samples were prepared for microscopic examination 
and plasma and liver samples were stored at -70℃  for later 
assays.
Platelet aggregation 
Platelet aggregation was measured using a Chronolog Whole 
Blood Aggregometor (model 500-Ca, Havertown, Pennsylvania, 
USA), of which the instrumental principle is based on the 
increase in impedance (Ω) across two platinum electrodes as 
platelet aggregation proceeds. The whole blood was diluted with 
isotonic saline (1:4) to give platelet concentration of approximately 
200,000 platelets/μl. Adenosine diphosphate (ADP, 2 μM) was 
added to initiate aggregation, and three readings of impedance 
changes were averaged for each rat.
Plasma and liver lipid assays 
Plasma total cholesterol, HDL-cholesterol and triglyceride were 
assayed using enzymatic kits (Asan Pharmaceuticals, Korea). Ten 
μl of plasma was used for the assays of total cholesterol and 
triglyceride. A 200 μl sample of plasma was incubated with 
dextran sulfate to precipitate apo B containing lipoprotein and 
50  μl of the supernatant was used for HDL cholesterol.
Liver lipids were extracted by a modified Folch method (Folch 
et al., 1957). One gram of liver tissue was homogenized for 5 
min in 6ml of Folch solution [chloroform (2): methanol (1)] and 
2ml H2O. After centrifugation for 10 min, the lower phase that 
contains liver lipids was separated. Lower phase of lipid fractions 
was assayed after treating with triton X-100:chloroform (25 μ
l:475 μl) for total cholesterol or with methanol for triglyceride, 
using enzymatic kits (Asan Pharmaceuticals, Korea). 
Na Efflux Channels
Red cell preparation: 
Blood was centrifuged at 1,000 ×g for 10 minutes, and the 
plasma and buffy coat were removed. Red blood cells were 
washed 5 times with a cold isotonic washing solution [150 mM 
choline chloride, 10 mM Tris-4 morpholinopropane sulfonic acid 
(MOPS), pH 7.4 at 4℃], and centrifuged at 1,000 ×g for 5 
minutes after each wash. The RBC pellet was resuspended in 
the choline chloride washing to give 40-50% hematocrit, which 
was also measured. A 50ul aliquot of the RBC suspension was Jung Lye Kim et al. 213
Table 2. Effects of onion and beet on growth rate and feed intake in simvastatin
treated hypercholesterolemic rats
 Control Simvastatin Simvastatin 
+ Onion
Simvastatin 
+ Beet
 Cholesterol  based  diet
Final B.W (g) 344.3 ± 39.5 353.6 ± 22.4 351.1 ± 21.2 356.1 ± 21.1
ADG
1)  (g/d)  4.74 ± 0.93  5.07 ± 0.81  5.00 ± 0.89  5.16 ± 0.98
ADFI
2)  (g/d) 17.06 ± 2.07 17.55 ± 1.34 15.10 ± 1.12 15.87 ± 1.19
FER
3)   0.28 ± 0.11  0.29 ± 0.07  0.33 ± 0.07  0.33 ± 0.04
LW/BW
4)  (%)  4.55 ± 0.33  4.45 ± 0.36  4.58 ± 0.45  4.53 ± 0.53
1) A D G :  A v e r a g e  d a il y  g a i n
2) ADFI:  Average  daily  feed  intake 
3) FER  :  Feed  Efficiency  Ratio
4) LW/BW:  Liver/Body  weight  ratio
Values  are  means ± SD  of  10  rats. 
Table 3. Effects of onion and beet on plasma and liver lipids in simvastatin
treated hypercholesterolemic rats
Control Simvastatin Simvastatin 
+ Onion
Simvastatin 
+ Beet
Cholesterol based diet
Plasma (mg/dl)
  Total-cholesterol* 172.6 ± 26.9
c 283.6 ± 48.7
a** 240.6 ± 65.3
b 266.6 ± 73.3
b
  HDL-cholesterol*  27.8 ± 5.7
b  21.8 ± 9.2
c  26.9 ± 9.7
b  41.4 ± 9.3
a**
  Triglyceride  65.0 ± 14.3  69.6 ± 16.4  62.0 ± 21.4  67.3 ± 21.5
Liver (mg/g)
  Total-cholesterol  32.9 ± 8.3  33.9 ± 6.9  33.3 ± 6.1  36.9 ± 6.4
  Triglyceride*  26.0 ± 4.1
ab  22.0 ± 16.5
b  30.5 ± 3.7
a  28.0 ± 6.5
ab
* *V a l u e s  c o m p a r e d  w i t h  t h e  l o w e s t  v a lu e  in  t h e  s a m e  r o w  d i f f e r  (p<0.01). 
* Values  in  the  same  row  not  sharing  the  same  superscript  differ ( p <0.05). 
Values  are  means ± SD  of  10  rats. 
added to 5ml of 0.025% acationox (a metal free detergent, 
Scientific products, McGraw Park, Illinois, USA) to be used for 
determination of intracellular Na concentrations. 
Na efflux:
Four ml each of the RBC suspension were added to 40ml 
MgCl2  medium with and without ouabain (70 mM MgCl2, 10 
mM KCl, 85 mM sucrose, 10 mM glucose, 10 mM Tris MOPS 
pH 7.4 at 37℃, 1 mM ouabain) for determination of Na efflux 
via Na-K ATPase. Two ml of the RBC suspension was added 
to 40 ml of choline chloride medium with and without furosemide 
(150 mM choline chloride, 10 mM glucose, 1 mM ouabain, 10m 
Tris-MOPS pH 7.4 at 37℃, 1 mM furosemide) for determination 
of Na efflux via Na-K cotransport. The RBCs in each medium 
were mixed and aliquoted into 12 tubes. Tubes in duplicate were 
transferred to an ice bath after incubation at 37℃ in a shaking 
water bath for 0, 2, 4, 6, 8, and 10 minutes for Na-K ATPase 
and 0, 10, 20, 30, 40 and 50 minutes for the Na-K cotransport. 
Tubes were centrifuged at 1,000 ×g for 5 minutes and then the 
supernatant was removed and measured for Na concentration 
using Atomic Absorption Spectrophotometer (Shimadzu model 
AA6701F).
Calculation:
Ouabain sensitive Na-K ATPase can be blocked by ouabain 
and furosemide sensitive Na-K cotransport can be blocked by 
furosemide. Sodium efflux via Na-K ATPase was calculated as 
the difference between the efflux into MgCl2  medium with ouabain 
and the efflux into MgCl2  medium without ouabain; Na-K cotransport 
was calculated as the difference between the efflux into choline 
chloride medium with furosemide and the efflux into choline 
chloride medium without furosemide; Na passive leak was 
calculated as the efflux into choline chloride medium that 
contained ouabain and furosemide. For the determination of the 
efflux via Na-K ATPase with 4 ml erythrocyte suspension added 
to 40 ml MgCl2  medium, the following calculation was used 
(Kang  et al., 1990).
Na  μg/(ml×min)×60 min×μmole/23 μg×[44 ml-(4 ml×hct)/(4 
ml×hct)]×=μmole/ml rbc/hour (mmole/ℓ rbc/hour) 
For the determination of intracellular Na concentration with 
50  μl red cell suspension added to 5ml 0.02% acationox, the 
following calculation was used; 
Na μg/(ml×min)×60 min×μmol/23 μg×101/hct = μmole/ml rbc 
(mmole/ℓ rbc) 
Histological examination 
Two parts of liver and aorta samples each were obtained from 
four rats per group. After being washed with saline, samples were 
fixed in 10% formalin for 48 hours and dehydrated in xylene 
for 18 hours. Samples were then embedded in paraffin and cut 
into 4-5 um cross section. Tissues were stained with hematoxylin- 
eosin for microscopic observation. 
Statistical analysis 
Values were statistically analyzed using the SAS package 
(SAS, 1994). Analysis of variance was conducted in a completely 
randomized block design. Duncan’s multiple range test was 
applied to compare individual means when F-value was significant 
(p<0.05). 
Results
Weight gain and food efficiency
The final body weight along with average daily gain (ADG) 
was not different among groups (Table 2). The feed efficiency 
ratio (FER) tended to be a little higher in fiber containing 
SIM-onion and SIM-beet groups. There was no difference in 
liver/body weight ratio (LW/BW).
Plasma and liver cholesterol and triglyceride
All groups fed diets containing simvastatin were significantly 
increased in plasma total cholesterol and the difference between 
the control and SIM group was significant (p<0.01) (Table 3). 
Plasma total cholesterol in SIM-onion and SIM-beet groups was 
significantly decreased compared with SIM group (p<0.05). 214 Onion and beet in simvastatin treated hypercholesterolemic rats
Table 4. Effects of onion and beet on platelet aggregation in simvastatin treated
hypercholesterolemic rats
 
Control Simvastatin Simvastatin 
+ Onion
Simvastatin 
+ Beet
Cholesterol based diet
Hematocrit (%) 41.8 ± 1.4 43.5 ± 1.8 42.0 ± 1.8 42.6 ± 1.2
Platelet Aggregation        
  Maximum (Ω)
1)  7.5 ± 1.6
b  7.0 ± 0.1
b  8.4 ± 1.5
a  7.1 ± 1.1
b
  Initial Slope (Ω/min)
2) 10.7 ± 3.1
ab  9.0 ± 2.4
b  12.8 ± 2.1
a  11.0 ± 2.1
ab 
1) Maximum  aggregation  is  ohm  at  the  point  where  aggregate  dissociated. 
2) Initial  slope  is  ohm  change  for  the  first  one  minute  of  aggregation. 
V a l u e s  i n  t h e  s a m e  r o w  n o t  s h a r i n g  t h e  s a m e  s u p e r s c r ip t  d i f f e r  (p<0.05) 
Values  are  means ± SD  of  10  rats.
Table 5. Effects of onion and beet on Na efflux in simvastatin treated 
hypercholesterolemic rats
Control Simvastatin  Simvastatin 
+ Onion
Simvastatin 
+ Beet
Cholesterol based diet
 Na  mmole/ℓ rbc
Intracellular Na
1) 2.98 ± 0.42 2.87 ± 0.31 3.12 ± 0.31 3.00 ± 0.38
Na Efflux Na mmole/ℓ rbc/hr
  Na-K ATPase
2) 0.39 ± 0.09
a 0.21 ± 0.10
b 0.36 ± 0.12
a 0.36 ± 0.15
a
  Na-K cotransport
3) 0.27 ± 0.08
a 0.18 ± 0.08
ab 0.24 ± 0.09
a 0.19 ± 0.04
ab
  Na passive leak
4) 0.14 ± 0.06
b 0.28 ± 0.12
a 0.25 ± 0.10
a 0.29 ± 0.09
a
  Total Na efflux 0.81 ± 0.10
a 0.67 ± 0.12
b 0.85 ± 0.12
a 0.84 ± 0.11
a
1) Intracellular Na ; upper values are for intact red blood cells. (Na mmole/ℓ rbc).
2) Na-K  ATPase  is  ouabain  sensitive  Na  efflux  through  Na-pump  (Na  mmole/ℓ 
rbc/hr).
3) N a - K  c o t r a n s p o r t  i s  f u r o s e m id e  s e n s i t iv e  N a  e f f lu x  t h r o u g h  N a - p ump  (Na 
mmole/ℓ r b c / h r ) .
4) Na-passive is Na efflux through passive sodium channel in intact red blood cells.
V a l u e s  i n  t h e  s a m e  r o w  n o t  s h a r i n g  t h e  s a m e  s u p e r s c r ip t  d i f f e r  (p<0.05)
Values  are  means ± SD  of  10  rats.
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Fig. 1. Microscopic appearance of liver tissue and aorta tissue (×400)
HDL-cholesterol was significantly increased in SIM-beet group 
compared with other groups (p<0.05). There was virtually no 
difference in plasma triglyceride among groups.
Liver total cholesterol was not different between any two 
groups, but liver triglyceride was significantly different between 
SIM group and SIM-onion group (p<0.05).
Whole blood platelet aggregation
Hematocrit was not different between any two groups (Table 
4). Platelet aggregation in both the maximum aggregation and 
initial slope was significantly increased in SIM-onion group 
compared with simvastatin group (p<0.05).
Na efflux channels
Erythrocyte Na efflux through Na-K ATPase was significantly 
decreased in SIM group compared with the control, SIM-onion 
and SIM-beet group (p<0.05). Na efflux through Na-K 
cotransport was also decreased in SIM group compared with the 
control and SIM-onion group. Na passive leak was significantly 
increased in all groups treated with simvastatin compared to the 
control (p<0.05). The total Na efflux was decreased significantly 
in SIM group compared with all other groups (p<0.05). There 
was no statistical difference in intracellular Na among groups. 
Histological examination of liver and aorta
Despite of higher plasma cholesterol, fat accumulation of liver 
tissue in simvastatin and SIM-onion groups appeared less than 
that of the control (Fig. 1). Endothelium of aorta tissue of the Jung Lye Kim et al. 215
control looked more rumpled than that of groups treated with 
simvastatin.
Discussion
Higher food efficiency ratio in SIM-onion and SIM-beet can be 
attributed to short chain fatty acids produced from fermentation 
of fibers in onion and beet. Some of undigested natural fiber 
can be fermented to propionate and acetate and absorbed in the 
large intestine (Lambo-Fodje et al., 2006). Plasma total cholesterol 
was increased in all groups treated with simvastatin opposing 
to our expectation. Condo et al. (1996) reported atorvastatin at 
1, 3, 10 or 20 mg/kg BW in guinea pig decreased plasma and 
liver cholesterol with reduced HMG CoA reductase in a 
dose-dependent manner. Pravastatin or fluvastatin at dose of 2 
mg/kg or 4 mg/kg BW respectively did not change plasma total 
cholesterol in rats (Chen et al., 2003). Pravastatin at high dose 
as 40 mg/kg or fluvastatin 20 mg/kg BW (Bełtowski et al., 2002) 
in Wistar rats and rosuvastatin at 20 mg/kg Bw in SHR rats 
(Susic  et al., 2003) had no effect on plasma HDL, total 
cholesterol and triglyceride. However, simvastatin 2 mg/kg BW 
we used in the present study did act on cholesterol metabolism 
causing an increase in plasma total cholesterol and a decrease 
in HDL cholesterol. Simvastatin, 80 mg/day or 1.8 mg/kg BW 
per day in human is the maximal approved dose and effective 
in lowering cholesterol (Lutjohann et al., 2004). Rat model may 
differ from human and guinea pigs in the cholesterol synthesis 
compartment, the plasma distribution of cholesterol and the 
processing of lipoprotein in plasma compartment. Unlike human 
in whom approximately 65% of total endogenous cholesterol is 
synthesized in extrahepatic tissues, the major site of cholesterol 
synthesis in the rat is liver (West et al., 2004). According to 
Fernandez (2001), plasma LCAT (lecithin-cholesterol acyltransferase) 
and CETP (cholesteryl ester transfer protein) in human and 
guinea pig are very active, while those enzymes in rat or mice 
are negligible therefore the plasma cholesteryl ester in rat is 
produced by liver ACAT (Acyl CoA-cholesterol acyltransferase) 
and released. The majority of circulating cholesterol in human 
and guinea pig is transported in LDL, but cholesterol in rats is 
carried by HDL fraction (Fernandez, 2001). West et al., (2004) 
reported that simvastatin is a lipophilic drug, which crosses 
membrane layers and influences cholesterol synthesis in 
extrahepatic tissues as well as in the liver, but there was a 
differential effect among species on HMG CoA reductase activity 
and mRNA synthesis. The different action mode among species 
can explain the discrepancy in hypocholesterolemic effect of 
statins. Onion and beet were effective in reducing plasma total 
cholesterol, which may be attributed to the fiber in onion and 
beet. Short chain fatty acids (SCFA) produced by microflora in 
the large intestine suppress cholesterol synthesis in rat liver and 
intestine (Hara et al., 1999), and SCFA produced from sugar 
beet fiber decreased plasma cholesterol by interrupting enterohepatic 
bile circulation (Hara et al., 1998). S-methyl cysteine sulfoxide 
in onion family suppresses HMG CoA reductase (Kumari & 
Augusti, 2007). Onion and beet in the present study showed a 
favorable effect of increasing HDL-cholesterol which is beyond 
any reasonable explanation. There is a report that daily consumption 
of 300 gram tomato for one month increased HDL cholesterol 
in human (Blum et al., 2006). 
Induction of nitric oxide (NO) by statin is one factor for 
suppressing platelet aggregation (Chou et al., 2008), while 
depletion of plasma antioxidant ubiquinol by statin therapy is 
another factor for activating platelet aggregation (Pignatelli et 
al., 2006). Theoretically, statin itself could hardly affect platelet 
aggregation as shown in the present study. Platelet aggregation 
may be controlled by much more complicated mechanism than 
we thought. Most of previous studies have reported that onion 
has antiplatelet effect (Briggs et al., 2001; Hubbard et al., 2006), 
but onion in the present study increased platelet aggregation in 
the initial slope and the maximum. Thiosulfinates have been 
implicated as a principle source of the antiplatelet property of 
raw onion and garlic juice (Briggs et al., 2001). Hubbard et al. 
(2006) showed that antioxidant quercetin in onion is involved 
in tyrosine phosphorylation in the signaling pathway causing 
reduced platelet aggregation. Antiplatelet compounds such as 
herb extracts can suppress platelet activity in vitro at high 
concentration but at low concentration, those can stimulate 
platelet aggregation. Healthy platelets can be dissociated from 
their aggregate under certain physiological condition. Platelet 
dissociation and survival after aggregation depends on the 
concentration of platelet suppressing compounds in medium 
(Chew et al., 2001). Previous studies (Briggs et al., 2001; Chew 
et al., 2001) that had antiplatelet effects of onion were conducted 
in the in vitro system, while the effect of onion on platelet 
aggregation in the present study was performed in vivo. Differences 
in experimental protocols and species must be taken into consideration 
for interpretation on platelet activity. 
Cholesterol lowering agent statin may decrease the membrane 
ratio of cholesterol/phospholipid, which may cause increase in 
membrane fluidity and increase in Na-K ATPase. Higher membrane 
cholesterol and lower Na-K ATPase were observed in the 
erythrocyte of hyperlipidemic patients (Broncel et al., 2007). 
Broncel et al. (2007) reported that fluvastatin at 80 mg/day in 
human decreased plasma total cholesterol and triglyceride and 
increased erythrocyte Na-K ATPase and Na-K cotransport. Statin 
in the present study rather increased plasma cholesterol, consequently 
increased membrane rigidity, and decreased Na-K ATPase. Statin 
induced nitric oxide synthetase (NOS) increasing cellular NO 
which in turn activates Na-K ATPase (Varela et al., 2004). On 
the other hand, Bełtowski et al. (2007) reported that NO decreased 
renal Na-K ATPase by stimulating cGMP and superoxide radicals 
and increased Na-K ATPase by depleting NO in leptin induced 
obese rats. Exposure of enterocytes to a NO donor, S-nitroso- 
N-acetlypenicillamine (SNAP), induced enterocyte injury in 
cultured intestinal epithelial cells, causing decrease in Na-K 216 Onion and beet in simvastatin treated hypercholesterolemic rats
ATPase (Suzuki et al., 2005). This discrepancy in the effect of 
NO and oxygen radical on Na-K ATPase may be attributed to 
the dual effects of NO. Quercetin rich in onion and betalain rich 
in beet are recognized to be bioavailable antioxidants and prevent 
membranes from damage by free radicals. Oxidative damage of 
membrane causes alterations on membrane channels. Decrease 
in platelet membrane fluidity and Na-K ATPase were observed 
in patients with ischemic stroke (Nanetti et al., 2008). 
In conclusion, despite reports that statins at even high dose 
as 20-40 mg/kg did not affect plasma total cholesterol in rats 
or mice, simvastatin at 2 mg/kg BW in the present experiment 
was enough to act on cholesterol metabolism, increasing plasma 
total cholesterol in rats. This dose is comparable to the maximum 
approved dose effectively lowering plasma cholesterol in human. 
The discrepancy on these results can be explained by the species 
difference in the metabolic pathway of cholesterol metabolism. 
Unlike antiplatelet action of onion in previous studies (Briggs 
et al., 2001; Chew et al., 2001; Hubbard et al., 2006), onion 
in the present study acted not as platelet suppressant but as 
stimulant where the platelets with high dissociation would have 
high survival rate after aggregation. In this study, simvastatin, 
which is a structural analog of HMG CoA thereby inhibiting 
HMG CoA reductase, increased plasma cholesterol and reduced 
Na-K ATPase and Na-K cotransport, and consequently decreased 
the total Na efflux. The results indicate that simvastatin apparently 
plays different roles in the cholesterol metabolism in rat differently 
from those in human. 
Literature cited
Bełtowski J, Borkowska E, Wójcicka G & Marciniak A (2007). 
Regulation of renal ouabain-resistant Na+-ATPase by leptin, nitric 
oxide, reactive oxygen species, and cyclic nucleotides: implications 
for obesity-associated hypertension. Clin Exp Hypertens 29:189- 
207.
Bełtowski J, Wójcicka G & Jamroz A (2002). Differential effect of 
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on 
plasma paraoxonase 1 activity in the rat. Pol J Pharmacol 54:661- 
671. 
Blum A, Merei M, Karem A, Blum N, Ben-Arzi S, Wirsansky I & 
Khazim K (2006). Effects of tomatoes on the lipid profile. Clin 
Invest Med 29:298-300.
Briggs WH, Folts JD, Osman HE & Goldman IL (2001). Adminis-
tration of raw onion inhibits platelet-mediated thrombosis in dogs. 
J Nutr 131:2619-2622. 
Broncel M, Balcerak M, Cieślak D, Duchnowicz P & Chojnowska- 
Jezierska J (2007). Effect of fluvastatin extended release on the 
protein-lipid structure of erythrocyte membrane and C-reactive 
protein in patients with hyperlipidemia. Pol Merkur Lekarski 
22:107-111.
Chen J, Nagasawa Y, Zhu BM, Ohmori M, Fujimura A & Hashmoto 
K (2003). Pravastatin prevents arrhythmias induced by coronary 
artery ischemia/reperfusion in anesthetized normocholesterolemic 
rats.  J Pharmacol Sci 93:87-94.
Chew DP, Bhatt DL & Topol EJ (2001). Oral glycoprotein IIb/IIIa 
inhibitors: why don’t they work? Am J Cardiovasc Drugs 1:421- 
428. 
Chou TC, Lin YF, Wu WC & Chu KM (2008). Enhanced nitric oxide 
and cyclic GMP formation plays a role in the anti-platelet activity 
of simvastatin. Br J Pharmacol 153:1281-1287.
Condo K, Vergara-Jimenez M, Krause BR, Newton RS & Fernandez 
ML (1996). Hypocholesterolemic action of atorvastatin are associated 
with alterations on hepatic cholesterol metabolism and lipoprotein 
composition in guinea pig. J Lipid Res 37:2372-2382.
Fernandez ML (2001). Guinea pigs as models for cholesterol and 
lipoprotein metabolism. J Nutr 131:10-20.
Folch J, Lee M & Sloane Stanley GH (1957). A simple method for 
the isolation and purification or total lipids from animal tissues. 
J Biol Chem 226:497-509. 
Fontaine D, Fontaine J, Dupont I, Dessy C, Carpentier Y & Berkenboom 
G (2002). Chronic hydroxymethylglutaryl coenzyme A reductase 
inhibition and endothelial function of the normocholesterolemic rat: 
comparison with angiotensin-converting enzyme inhibition. J 
Cardiovasc Pharmacol 40:172-180.
Hara H, Haga S, Aoyama Y & Kiriyama S (1999). Short-Chain Fatty 
Acids Suppress Cholesterol Synthesis in Rat Liver and Intestine. 
J Nutr 129:942-948.
Hara H, Haga S, Kasai T & Kiriyama S (1998). Fermentation 
Products of Sugar-Beet Fiber by Cecal Bacteria Lower Plasma 
Cholesterol Concentration in Rats. J Nutr 128:688-693.
Hubbard GP, Wolffram S, de Vos R, Bovy A, Gibbins JM & 
Lovegrove JA (2006). Ingestion of onion soup high in quercetin 
inhibits platelet aggregation and essential components of the 
collagen-stimulated platelet activation pathway in man: a pilot 
study.  Br J Nutr 96:482-488.
Kang JS, Cregor MD & Smith JB (1990). Effect of calcium on blood 
pressure, platelet aggregation and erythrocyte sodium transport in 
Dahl salt-sensitive rats. J Hypertens 8:245-250.
Kanner J, Harel S & Granit R (2001). Betalains-a new class of dietary 
cationized antioxidants. J Agric Food Chem 49:5178-5185. 
King DE & Mainous AG, Player A & Geesey ME (2007). Use of 
statins and blood pressure. Am J hypertens 20:937-941.
Kumari K & Augusti KT (2007). Lipid lowering effect of S-methyl 
cysteine sulfoxide from Allium cepa Linn in high cholesterol diet 
fed rats. J Ethnopharmacol 109:367-371. 
Lambo-Fodje AM, Oste R & Nyman ME (2006). Short-chain fatty 
acid formation in the hindgut of rats fed native and fermented oat 
fibre concentrates. Br J Nutr 96:47-55. 
Lutjohann D, Stroic M, Bertsch T, Lindenthal B, Andersson U & 
Fassbender K (2004). High doses of simvastatin, pravastatin and 
cholesterol reduce brain cholesterol synthesis in guinea pig. 
Steroids 69:431-438.
Mabuchi H, Higashikata T, Kawashiri M, Inazu A, Koizumi J & 
Kobayashi J (2005). Reduction of serum ubiquinol-10 and ubiquinone- 
10 levels by atorvastatin in hypercholesterolemic patients. J 
Atheroscler Thromb 12:111-119.
Nakamura H (2007). Primary prevention of cardiovascular diseases 
among hypercholesterolemic Japanese with a low dose of pravastatin. 
Atherosclerosis Suppl 8:13-17.
Nanetti L, Vignini A, Raffaelli F, Silvestrini M, Provinciali L & 
Mazzanti L (2008). Platelet membrane fluidity and Na+/K+ 
ATPase activity in acute stroke. Brain Res 1205:21-26. 
Pignatelli P, Di Santo S, Buchetti B, Sanguigni V, Brunelli A & Violi 
F (2006). Polyphenols enhance platelet nitric oxide by inhibiting 
protein kinase C-dependent NADPH oxidase activation: effect on Jung Lye Kim et al. 217
platelet recruitment. FASEB J 20:1082-1089. 
Rosamond W (2008). Heart disease and stroke statistics: A report from 
the American Heart Association Statistics Committee. Circulation 
117:e25-e146.
Susic D, Varagic J, Ahn J, Slama M & Frohlich ED (2003).Beneficial 
pleiotropic vascular effects of rosuvastatin in two hypertensive 
models.  J Am Coll Cardiol 17; 42:1091-1097. 
Suzuki Y, Lu Q, Xu DZ, Szabó C, Haskó G & Deitch EA (2005). 
Na+, K+-ATPase activity is inhibited in cultured intestinal epithelial 
cells by endotoxin or nitric oxide. Int J Mol  Med 15:871-877. 
Tesoriere L, Allegra M, Butera D & Livrea MA (2004). Absorption, 
excretion, and distribution of dietary antioxidant betalains in LDLs: 
potential health effects of betalains in humans. Am J Clin Nutr 
80:941-945. 
Varela M & Garvin JL (2004). Acute and chronic regulation of thick 
ascending limb endothelial nitric oxide synthase by statins. J Am 
Soc Nephrol 15:269-275.
West KL & Fernandez ML (2004). Guinea pigs as models to study 
the hypocholesterolemic effects of drugs. Cardiovasc Drug Rev 
22:55-70.
Yamamoto Y, Aoyama S, Hamaguchi N & Rhi GS (2005). Antioxidative 
and antihypertensive effects of Welsh onion on rats fed with a high-fat 
high-sucrose diet. Biosci Biotechnol Biochem 69:1311-1317. 